Avidity Partners Management LP Sells 91,100 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)

Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]

Related Keywords

Canada ,United States , ,Eagle Asset Management Inc ,Nasdaq ,Lighthouse Investment Partners ,Needham Company ,Royal Bank ,Canaccord Genuity Group ,Regal Investment Advisors ,Avoro Capital Advisors ,Cellular Therapies Inc ,Schroder Investment Management Group ,Avidity Partners Management ,Intra Cellular Therapies ,Free Report ,Cellular Therapies ,Partners Management ,Capital Advisors ,Investment Partners ,Investment Advisors ,Investment Management Group ,Eagle Asset Management ,Asset Management ,Get Free Report ,Genuity Group ,Intra Cellular Therapies Daily ,